Skip to main content
JOhn Smith on Muck Rack

JOhn Smith

As seen in: Bored Panda, cnblogs.com, The Run Time, EIN Presswire, Prsync.com, Sooper Articles, ATV.COM, Australian Journal of Pharmacy, The AJP Podcast, Bruges Group and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with JOhn

Contact JOhn, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

April MIMS update

|
By John Smith, JOhn Smith, Edward A. Hatfield, Nicholas O’Donoghue
| Australian Journal of Pharmacy Verified
Some of the recent changes to the medicines landscape, with new products and indications New Products Fedratinib (as dihydrochloride monohydrate) (Inrebic) is an oral kinase inhibitor with activity against wild type and mutationally activated Janus Associated Kinase (JAK) 2 and FMS-like tyrosine kinase 3 (FLT3). Fedratinib is a JAK2-selective inhibitor with higher inhibitory activity for This content is restricted to registered users only.
Open in Who Shared Issue with article?

‘Step fully into your role as a prevention leader’

|
By Michael Khoo, John Smith, JOhn Smith, Antony McElroy
| The AJP Podcast
No trading dispensing fees for full scope: Twomey Guild warns it will step away from its pursuit of full scope of practice if dispensing remuneration becomes a bargaining… ‘They’re our future’ Karen Brown shares her “proud mum” moment on seeing her former intern become pharmacist manager of her newest store, and… Asian pharmacy giant eyes Infinity Global health and beauty retail behemoth joins list of suitors looking to acquire collapsed pharmacy group, Infinity One of the largest pharmacy...
Open in Who Shared Issue with article?

The renin-angiotensin-aldosterone system—what is it, and how does it affect blood pressure?

|
By Peter Carroll, Peter Coomber, John Smith, JOhn Smith
| Australian Journal of Pharmacy Verified
Back to Basics with Peter Carroll The aim of this series of articles is to revisit and discuss some fundamental pharmacological, physiological and therapeutic concepts with the overall objective of “keeping it simple”. What is the renin-angiotensin-aldosterone system (RAAS) and how does it affect blood pressure? By Professor Peter Carroll AM, School of Medicine, University This content is restricted to registered users only.
Open in Who Shared Issue with article?
See all 387 articles